Profile of the Guidance document for the Regulatory requirements for intravenous immunoglobulin products in Canada

From: Health Canada


The purpose of this guidance document is to provide guidance to sponsors of intravenous immunoglobulin (IVIG) products on the regulatory requirements, particularly minimum clinical data requirements for submissions involving approved and non-approved IVIG products in Canada.

In this guide

View complete guide
Download PDF (675 KB, 12 pages)

Details and history

Page details

Date modified: